EM-T3Expert Opinion on Drug Safety2024-07-17第 24 卷第 8 期,1001-1010高影响力 · 前 10%
Comparing musculoskeletal and connective tissue disorder risks of teriparatide and abaloparatide in osteoporosis: an analysis based on FDA adverse event reporting system (FAERS)